Samantha Peacock

Samantha’s experience includes advising:

Venture Capital - Investor Side

• Octopus Ventures on its investments into Vira Health, Automata, and Touchlab spanning from pre-seed to Series B
• Hoxton Ventures on its lead investments in Skin Analytics, Bother, Slice, and Luminary ROLI
• VEON Ventures on its strategic investments in the Series A and B rounds of into Bangladesh based ShopUp in and Series A round of Pakistan based Dastgyr
• Novo on its Series D investment in Quanta Dialysis
• Citi Ventures on its investment in GoHenry’s US$40 million funding round
• GIC, JP Morgan, and HSBC’ Venture Capital Fund on their Series B+ investments in Miotech, an ESG data start up
• HSBC Investment Bank on its Series B investments in Miotech, Callsign, and Silent Eight

Venture Capital - Company Side

• WorldRemit on its US$292 million Series E funding round
• Toqio on its seed funding round led by Seaya and Speedinvest
• LifeScore on its £11m Series A financing led by Octopus Ventures and Warner Music Group
• Aztec Network on its Series A funding round led by Paradigm
• Fertifa Limited, the UK’s first and leading reproductive healthcare benefits provider and provider of a next-generation fertility clinic, on its seed funding round led by Passion Capital

Life Sciences and Healthcare

• Novo Holdings on its agreement to acquire the Norwegian fish genetics company Benchmark Genetics from Benchmark Holdings plc for an enterprise value of up to £260 million
• Norgine, a European specialty pharmaceutical company, on the sale of a controlling stake to Goldman Sachs Asset Management
• Alliance Pharma on its acquisition of US scar treatment brand, ScarAway
• Theramex, a global specialty pharmaceutical company dedicated to women’s healthcare, in connection with the US$703 million acquisition by CVC of women’s healthcare assets from Teva 
• TLS Beta on the acquisition of a 30% stake in Stamford Devices, an Ireland-based provider of medical device and drug delivery services and holding company for Aerogen 
• Actavis UK and Actavis Ireland on its £603 million divestment by Teva to Intas* 
• Accelovance Inc on its cross-border acquisition of THERAMetrics Holding AG’s CRO subsidiaries in Italy, Germany, and Romania* 
• Adorial on its acquisition by C4X Discovery Holdings plc*
• Actavis on its £306 million acquisition of Auden Mckenzie, a pharmaceutical company specialising in the development, licensing and marketing of generic medicines and proprietary brands, making Actavis the largest generics company in the UK
• Actavis on the divestment of part of its Western European generics sale and marketing business to Aurobindo*

Other

• CDPQ on its partnership with GIM and joint investment in FNZ, a deal valuing the company at £1.65 billion and being one of the world’s largest fintech transactions of 2018
• Thomas Cook on the sale of its Belgium airline business to Brussels Airlines, a subsidiary of Lufthansa
• H&F on the disposal of on the disposal of a minority interest in the Verisure Securitas Direct group to GIC
• Mimecast on the acquisition of Simply Migrate, a London-based provider of archive data migration technology
• Onex on its up to €3.75 billion acquisition of SIG Combibloc Group AG
• Acano in connection with its US$700 million acquisition by Cisco*
• Epicor Software Corporation in connection with its acquisition of Dot-Net-IT Limited*

*Matter handled prior to joining Latham